moxicum 400 mg/250 ml soluţie perfuzabilă
world medicine ilac san.ve tic. a.Ș. - moxifloxacinum - soluţie perfuzabilă - 400 mg/250 ml
moxicin 5 mg/ml picături oftalmice, soluţie
liqvor saÎ - moxifloxacinum - picături oftalmice, soluţie - 5 mg/ml
bivoxa 5 mg/ml picături oftalmice, soluţie
world medicine ilac san.ve tic. a.Ș. - moxifloxacinum - picături oftalmice, soluţie - 5 mg/ml
scemblix
novartis europharm limited - asciminib hydrochloride - leucemie, mielogenă, cronică, bcr-abl pozitivă - agenți antineoplazici - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leucemie mieloidă - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
lowenstein jensen + moxifloxacin 1 ug/ml
sc deltarom srl -
diphereline 11 25 mg 11,25 mg pulbere şi solvent pentru suspensie injectabilă cu eliberare prelungită
ipsen pharma - triptorelinum - pulbere şi solvent pentru suspensie injectabilă cu eliberare prelungită - 11,25 mg
halopril comprimate 1,5 mg
zdorovie narodu srl, if din harkov - aciclovirum - comprimate - 1,5 mg
halopril forte comprimate 5 mg
zdorovie narodu srl, if din harkov - aciclovirum - comprimate - 5 mg
sorbifer durules 320 mg + 60 mg comprimate filmate
egis pharmaceuticals plc - ferrosi sulfas + acid ascorbicum - comprimate filmate - 320 mg + 60 mg